| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Medicine A, Roswell Park Memorial Institute, Buffalo, New York 14203
Embryonic rat bones labeled with 45CaCl2 are stimulated in vitro by parathyroid extract to release 45Ca. Mithramycin prevents this active release over a broad range of dose levels that are nonlethal to the bones, as evidenced by their subsequent responsiveness to additional parathyroid extract. The similarity of dose levels used to concentrations (based on calculated dilution) after clinical administration supports the interpretation that clinical effects of mithramycin in hypercalcemic patients are due to a direct effect on bone.
1 This investigation was supported by USPHS Grant Ca-5834 from the National Cancer Institute.
Received 7/21/71. Accepted 9/15/71.
This article has been cited by other articles:
![]() |
M Segerling, S. Ohanian, and T Borsos Chemotherapeutic drugs increase killing of tumor cells by antibody and complement Science, April 4, 1975; 188(4183): 55 - 57. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |